Annual EBITDA
-$208.86 M
-$29.08 M-16.18%
December 31, 2023
Summary
- As of February 10, 2025, DCPH annual EBITDA is -$208.86 million, with the most recent change of -$29.08 million (-16.18%) on December 31, 2023.
- During the last 3 years, DCPH annual EBITDA has risen by +$60.03 million (+22.32%).
Performance
DCPH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$48.40 M
+$2.38 M+4.70%
March 1, 2024
Summary
- As of February 10, 2025, DCPH quarterly EBITDA is -$48.40 million, with the most recent change of +$2.38 million (+4.70%) on March 1, 2024.
- Over the past year, DCPH quarterly EBITDA has increased by +$4.83 million (+9.07%).
Performance
DCPH Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$204.61 M
+$4.25 M+2.04%
March 1, 2024
Summary
- As of February 10, 2025, DCPH TTM EBITDA is -$204.61 million, with the most recent change of +$4.25 million (+2.04%) on March 1, 2024.
- Over the past year, DCPH TTM EBITDA has increased by +$30.00 thousand (+0.01%).
Performance
DCPH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
DCPH EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -16.2% | +9.1% | +0.0% |
| 3 y3 years | +22.3% | +9.1% | +0.0% |
| 5 y5 years | -110.0% | +9.1% | +0.0% |
DCPH EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +16.2% | +42.2% | +12.6% | +81.0% | +13.8% | +45.2% |
| 5 y | 5-year | +16.2% | +42.2% | +12.6% | +81.0% | +13.8% | +45.2% |
| alltime | all time | +1091.2% | +42.2% | +699.8% | +81.0% | +3281.4% | +45.2% |
Deciphera Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$48.40 M(-4.7%) | -$204.61 M(-2.0%) |
| Dec 2023 | -$208.86 M(+16.2%) | -$50.78 M(-4.6%) | -$208.86 M(+2.1%) |
| Sep 2023 | - | -$53.22 M(+2.0%) | -$204.64 M(+4.6%) |
| Jun 2023 | - | -$52.20 M(-0.8%) | -$195.55 M(+5.0%) |
| Mar 2023 | - | -$52.65 M(+13.1%) | -$186.32 M(+3.6%) |
| Dec 2022 | -$179.78 M(-39.5%) | -$46.56 M(+5.5%) | -$179.78 M(-18.6%) |
| Sep 2022 | - | -$44.14 M(+2.7%) | -$220.84 M(-13.6%) |
| Jun 2022 | - | -$42.97 M(-6.8%) | -$255.61 M(-9.5%) |
| Mar 2022 | - | -$46.11 M(-47.4%) | -$282.41 M(-4.9%) |
| Dec 2021 | -$297.06 M(+10.5%) | -$87.62 M(+11.0%) | -$297.06 M(+9.3%) |
| Sep 2021 | - | -$78.91 M(+13.1%) | -$271.75 M(+6.1%) |
| Jun 2021 | - | -$69.77 M(+14.8%) | -$256.17 M(+0.5%) |
| Mar 2021 | - | -$60.76 M(-2.5%) | -$254.84 M(-5.2%) |
| Dec 2020 | -$268.88 M | -$62.30 M(-1.6%) | -$268.88 M(-1.6%) |
| Sep 2020 | - | -$63.33 M(-7.5%) | -$273.34 M(+2.8%) |
| Jun 2020 | - | -$68.45 M(-8.5%) | -$266.02 M(+21.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$74.80 M(+12.0%) | -$218.89 M(+14.4%) |
| Dec 2019 | -$191.36 M(+92.4%) | -$66.76 M(+19.2%) | -$191.36 M(+22.1%) |
| Sep 2019 | - | -$56.01 M(+162.7%) | -$156.78 M(+25.3%) |
| Jun 2019 | - | -$21.32 M(-54.9%) | -$125.10 M(-0.2%) |
| Mar 2019 | - | -$47.27 M(+46.9%) | -$125.37 M(+26.1%) |
| Dec 2018 | -$99.45 M(+98.8%) | -$32.18 M(+32.3%) | -$99.45 M(+14.2%) |
| Sep 2018 | - | -$24.33 M(+12.6%) | -$87.11 M(+16.5%) |
| Jun 2018 | - | -$21.59 M(+1.1%) | -$74.76 M(+17.3%) |
| Mar 2018 | - | -$21.35 M(+7.6%) | -$63.74 M(+27.4%) |
| Dec 2017 | -$50.04 M(+94.4%) | -$19.84 M(+65.7%) | -$50.04 M(+29.3%) |
| Sep 2017 | - | -$11.98 M(+13.3%) | -$38.70 M(+18.1%) |
| Jun 2017 | - | -$10.57 M(+38.1%) | -$32.78 M(+47.6%) |
| Mar 2017 | - | -$7.65 M(-10.0%) | -$22.21 M(+52.6%) |
| Dec 2016 | -$25.74 M(+46.8%) | -$8.50 M(+40.5%) | -$14.55 M(+140.5%) |
| Sep 2016 | - | -$6.05 M | -$6.05 M |
| Dec 2015 | -$17.53 M | - | - |
FAQ
- What is Deciphera Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Deciphera Pharmaceuticals?
- What is Deciphera Pharmaceuticals annual EBITDA year-on-year change?
- What is Deciphera Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Deciphera Pharmaceuticals?
- What is Deciphera Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Deciphera Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Deciphera Pharmaceuticals?
- What is Deciphera Pharmaceuticals TTM EBITDA year-on-year change?
What is Deciphera Pharmaceuticals annual EBITDA?
The current annual EBITDA of DCPH is -$208.86 M
What is the all time high annual EBITDA for Deciphera Pharmaceuticals?
Deciphera Pharmaceuticals all-time high annual EBITDA is -$17.53 M
What is Deciphera Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, DCPH annual EBITDA has changed by -$29.08 M (-16.18%)
What is Deciphera Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of DCPH is -$48.40 M
What is the all time high quarterly EBITDA for Deciphera Pharmaceuticals?
Deciphera Pharmaceuticals all-time high quarterly EBITDA is -$6.05 M
What is Deciphera Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, DCPH quarterly EBITDA has changed by +$4.83 M (+9.07%)
What is Deciphera Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of DCPH is -$204.61 M
What is the all time high TTM EBITDA for Deciphera Pharmaceuticals?
Deciphera Pharmaceuticals all-time high TTM EBITDA is -$6.05 M
What is Deciphera Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, DCPH TTM EBITDA has changed by +$30.00 K (+0.01%)